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Science cannot be contained. In the age of mass 
information, news of scientific innovation is rapidly 
translated from laboratories to academic publications to 
newspapers, especially when scientific breakthroughs 
offer new information about diseases and improved 
quality of life. Perhaps the most publicized scientific 
endeavor of the past 50 years has been the Human 
Genome Project (HGP), a national effort to locate 
and map every gene in the human body. For more 
than 50 years, the HGP was discussed and worked 
on in laboratories throughout the United States. The 
project was not a strictly scientific endeavor, however, 
but was integrated into congressional legislation, city 
council meetings, courtrooms, and pharmaceutical 
board meetings, where non-scientific communities 
responded to the HGP in disparate ways. As a result, the 
innovations and implementations of genetic research in 
the project were articulated and managed by people 
both inside and outside of the laboratory.
The HGP created a dynamic network of 
collaborations that involved not just scientists, but 
ethicists, community members, activists, and computer 
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scientists.1 While the mid-century intellectual origins of the project 
revealed language to be an important organizational tool for gene mapping, 
the gene nomenclature system was as much imposed by demands from 
communities and courtrooms as it was implemented by scientists. Although 
the history of the HGP has often been told as a set of events and discoveries, 
it can also be articulated as a narrative about people. When the history 
of the HGP is re-imagined in this way, it becomes clear that the project 
had informal mid-century origins long before its formal establishment in 
1990. Beginning with a set of lectures given by Erwin Schrödinger in 1943, 
the first section of this paper examines the importance of language as a 
periodization tool to explain the longer intellectual history of the HGP. The 
second section then traces the importance of language when non-scientific 
professionals and community members engaged with the large-scale 
implications of the HGP. The following is a story about language and about 
people—academics and ordinary citizens, geneticists and jurors—who 
influenced the organizational underpinnings of a deeply humanistic and 
scientific endeavor: a genetic map of the human body.
The HGP formally began in 1990, when the US Congress jointly 
funded the Department of Energy (DOE) and the National Institutes of 
Health (NIH) to map out the human genetic sequence. These institutions 
had different goals in mind when designing the HGP. While the DOE 
was interested in the project as an opportunity to study the long-term 
genetic effects of nuclear radiation, the NIH wanted to maintain 
its reputation as a leader of American scientific research. The HGP 
generated excitement within the scientific community. Indeed, it was 
completed in only 11 years when project architects anticipated a 15-year 
period to completion. The fact that the human genome was mapped 
nearly four years before its intended completion date is indicative 
of the large-scale intellectual, financial, technological, and cultural 
resources afforded the HGP. By 2001, the DOE and the NIH alone had 
1 A lso known as the material semiotic method, sociologist Bruno Latour’s Actor Network 
Theor y is a useful way to conceptualize the relationship between material objects and 
conceptual ideas in the Human Genome Project. The idea of a human gene map had many 
abstract qualit ies, including representing human disease cartographically and storing 
this information in a cyber database. There were also concerns over patients r ights and 
consent. In response to these concerns, individual and institutional actors cooperated in 
networks to map the human genome. For further information on Actor Network Theor y 
see Bruno Latour, Reassembling the Social: An Introduction to Actor-Network-Theory 
(Oxford: Oxford University Press, 2005).
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invested approximately 2.7 billion dollars in 
the project.2
A considerable amount of funding 
had been allocated to the development of 
new sequencing and database technologies 
to increase mapping efficiency and to 
reduce the cost of research. Still, scientists 
were inundated with a copious amount of 
information. Mass data yielded from the 
project raised questions about the storage, 
access, and ownership of genetic research. To 
address these concerns, scientists began to 
contemplate a coherent system of classification 
for the mapped genomic regions, which 
also incorporated standardized molecular 
nomenclature. Such a system was thought 
to benefit the HGP in several ways: communication standards could 
facilitate information exchange between laboratories, increase project 
efficiency and organization, and offer a solution for sharing the project’s 
findings to non-scientific communities. The story of the nomenclature 
system is, in fact, a story of how scientists and non-scientists responded 
to both organizational and ethical questions raised throughout 
the course of the HGP.
Historians disagree about both the formal and informal origins of the 
Human Genome Project. Literature on the history of genetics often begins 
with one of two origin points: in the nineteenth century with Gregor 
Mendel’s pea plants or with the formal discovery of DNA’s helical structure 
by either Rosalind Franklin or James Watson and Francis Crick in the 
1950s. Still, other scholarship charts the project’s formal commencement 
later, when institutional sponsorship and early HGP mapping efforts 
began in the late 1970s. Historiography on the HGP tends to periodize 
its progress around major events and findings, such as the preliminary 
mapping meetings held at Cold Spring Harbor Laboratory in the late 1970s. 
However, a study of the project’s intellectual momentum suggests that 
2 “International Consortium Completes Human Genome Project,” National Human 
Genome Research Institute, April 14, 2003, News Release A rchives, National 
Institutes of Health.
Literature on the history of 
genetics often begins with Gregor 
Mendel’s (pictured) pea plants 
or with the formal discovery of 
DNA’s helical structure by either 
Rosalind Franklin or James Watson 
and Francis Crick in the 1950s. 
(Photo courtesy of Wikimedia.)
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scholars had an established vision of a human gene map several decades 
prior to the institutional coalescence of the HGP in 1990. As intellectual 
momentum gave way to project implementation, the organizers of the 
HGP realized that different laboratories utilized different organizational 
systems for mapping genes. The confusion created by these discrepancies 
led the proponents of the HGP to advocate for a standardized language 
system that would facilitate communication and consistency among dozens 
of laboratories.3 In addition to the project’s chronological or event-based 
history, the HGP’s intellectual history can be traced through individual 
proponents of a language system for gene mapping. In order to understand 
the lengthy process of standardized language creation in the HGP, it is 
necessary to first turn to the intellectual origins of the project.
The Scientific Community and HGP Origins
At the end of the nineteenth century, Austrian abbot Gregor Mendel 
pioneered the study of genetics in plants. By the mid-twentieth century, 
the field of molecular biology was increasingly concerned with human, 
rather than plant, genes. The study of human genetics interested biologists 
because genes revealed information about the inheritance of human traits. 
The medical community was especially interested in creating a gene map as 
a means to better understand human propensity for disease. Collaboration 
between scientific and medical research communities promised new 
insights into gene expression and the likelihood of inheriting diseases such 
as cancer, cystic fibrosis, sickle cell anemia, and Huntington’s disease. 
In order to standardize either scientific or medical understandings of 
the human gene, however, some sort of unified vision of what was being 
discussed would be required.
One of the earliest descriptions of a human gene map was set forth 
by Austrian physicist Erwin Schrödinger in a series of published lectures 
3 Prior to the development of a single nomenclature system, geneticists had several options 
for naming genes. Gene names could be based on primar y function, location on the 
chromosome, numerical assignment, sequence tag site (STS), known genetic trait, disease 
associated with the gene, enzyme associated with the gene, etc. For further reading, see 
M.D. Zorn and C.R. Cantor, “Nomenclature Issues in the Human Genome Project,” in 
The Terminolog y of Biotechnolog y: A Multidisciplinary Problem (University of California, 
Berkeley, 1990).
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at Trinity College Dublin in 1943.4 According to Schrödinger, the human 
cell, like other biological mechanisms, required order. Order, he stated, 
was governed by physical laws that possessed a high degree of accuracy. 
Interactions between separate but related mechanisms were brought into 
harmony through order, from the microscopic order of cellular processes to 
the larger whole being governed by the human body. Whether microscopic 
or systemic, physical interactions of the body depended upon a distinct 
order with identifiable patterns, Schrödinger posited.
 Schrödinger was particularly concerned with the patterns that 
governed genetic structures. He understood that even the nearly invisible 
interactions of the quanta (the smallest amount of energy required for 
a physical interaction) informed and even defined visible biological 
interactions. Speaking specifically about the visibility of cellular material, 
Schrödinger noted, “Within every group [of genes] a linear map can be 
drawn up which accounts quantitatively for the degree of linkages between 
any two of that group, so that there is little doubt that they actually are 
located, and located along a line, as the rod-like shape of the chromosome 
suggests.”5 He was certain that it was possible to construct a linear map to 
organize and catalog a genetic “code-script,” and he aimed to study the 
relationships of these microscopic life-giving entities. For this, Schrödinger 
also had a solution: mapping.
Schrödinger did not live to see the human gene map to completion, 
but he was convinced that understanding genetic order was critical to its 
materialization. Although applied physics dominated early twentieth-
century research, Schrödinger believed that “the second half of the century 
will belong to molecular biology and genetics.” Schrödinger insisted that 
scientists had “reached a point of dramatic change in our views of life and 
ourselves,” and that “great discoveries [are] imminent.” He concluded by 
writing that the implications of genetic research “will change our culture.”6 
Schrödinger’s vision not only advanced intellectual discourse regarding 
4 Er win Schrödinger, What Is Life: The Physical Aspect of the Living Cell; with, Mind and 
Matter; & Autobiographical Sketches (Cambridge; New York: Cambridge University 
Press, 2012).
5 Er win Schrödinger, “What Is Life? The Physical Aspect of the Living Cell,” The American 
Naturalist , University of Chicago Press for The American Society of Naturalists 79, no. 785 
(1945): 554.
6 Johann Götschl, Erwin Schrödinger’s World View: The Dynamics of Knowledge and 
Reality, Theor y and Decision Librar y, vol. 16, Dordrecht (Boston: K luwer 
Academic, 1992).
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the nature and structure of genes, it also brought the concept of organized 
genomic mapping out of the realm of individual imagination to that of 
legitimate scientific possibility.
Despite Schrödinger’s prescience, the advancement of scientific 
understandings of genetic structure, function, and even location was 
modest during the 1940s. Scientific instrumentation remained insufficient 
for genetic visibility, and funding for the biological sciences was 
significantly diminished during wartime. However, this changed following 
World War II, when American scientific communities at large transitioned 
from a focus on applied science (science developed to enhance specific 
wartime projects, such as weapons manufacturing) to an emphasis on basic 
research (research that focused on creating or advancing new scientific 
knowledge). In July 1945, Vannevar Bush, Director of the United States 
Office of Scientific Research and Development, paved the way for this 
with his publication of Science: The Endless Frontier, a manifesto about 
the future of science written at the request of President Roosevelt. Bush 
insisted that basic research would be the “new frontier” of the scientific 
community.7 In the report, Bush suggested that science should support new 
7 Vannevar Bush, Science—the Endless Frontier: A Report to the President on a Program 
for Postwar Scientif ic Research (Washington, D.C.: National Science Foundation, 
reprint, 1980), Section 1 . Especially relevant to basic scientif ic research is a set of norms 
introduced in 1973 by sociologist Robert K. Merton in his work The Sociolog y of Science: 
Theoretical and Empirical Investigations. This landmark publication outlined ethical 
principles to guide modern scientif ic research.
Vannevar Bush, who predicted the shift from wartime applied science to postwar 
basic research. Bush was an early advocate for genetics research in the second 
half of the twentieth century. (Photo courtesy of Wikimedia.)
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efforts to understand human disease and infection, "yet we find that the 
traditional sources of support for medical research… are diminishing and 
there is no immediate prospect of a change in this trend.”12 Bush called for 
a move to support basic research, but he understood that most academic 
institutions could not independently support the large-scale research he 
had in mind. The genetics community benefitted from Bush’s proposed 
basic research funding because the field of genetics coalesced medicine and 
biology around disease prevention, a topic that Bush believed was crucial to 
the future of American scientific research. Indeed, Bush’s letter to Franklin 
D. Roosevelt did much to sway federal support in favor of the enterprise of 
biological research.
Though basic science was gaining prominence, it would still take 
time before the vision of a genomic map would have any concrete reality. 
Prior to gene mapping, geneticists focused on mapping the structure 
of chromosomes, which bound together smaller units of genetic 
information. Twelve years after Bush’s report, Albert Levan and Joe Hin 
Tjio, geneticists at the University of Lund, identified and published the 46 
human chromosomal structures. The findings of Levan and Tjio directly 
contradicted the prevailing belief that there were 48 human chromosomes. 
Prior to their publication, chromosomal research had been widely 
suspended, as chromosome number and structure were an essential basis 
for continued research. Whereas Schrödinger’s writings described the 
mapping of genomic structures as a viable scientific pursuit, Levan and 
Tjio defined chromosomes—the building blocks of human genetics—as 
entities that were open to further investigation. The process of peering 
into chromosomal structures that contained genetic material enhanced 
the depth and scale of microbiology, providing the possibility to discern 
the nature, structure, and functions of genetic material contained within 
each chromosome. Once the number of chromosomes had been accurately 
determined, the boundaries of genetic study could be defined both spatially 
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and visually, turning Schrodinger’s vision into reality.8
When Tjio and Levan discovered the structure and number of human 
chromosomes, their findings confirmed the viability of genetic mapping. 
During this revelatory moment, the scientific community turned to the 
question of language and nomenclature, which would be used to discuss 
a potential map of human chromosomes. By the mid-twentieth century, 
better microscopic lens resolution had led to more precise chromosome 
photographs, and geneticists speculated that genes on the chromosome 
might soon be studied in greater detail. If images of the chromosomes 
were to be translated into a map of chromosomes, the information had to 
be intelligible and navigable by scientists in different labs across the United 
States and around the world. Simply being able to see the same image 
was not enough.
Although Levan and Tjio’s discovery made a common nomenclature 
necessary, American scientists had already discussed the possibility of a 
standardized nomenclature system. In 1953, three years prior to Levan 
and Tjio’s publication, the NIH received a copy of a 76-page report titled, 
“A Proposal for Uniform Nomenclature in Bacterial Genetics.”9 A team of 
international geneticists had developed the proposal from a paper published 
at Brookhaven National Laboratory and sponsored by the US Atomic Energy 
Commission. It recommended a basic system for naming, referencing, and 
cataloging genetic information, thereby defending the importance of a 
nomenclature system from a number of perspectives.10 First, it suggested 
that such a system was convenient and pragmatic since individual research 
groups would not need to devise their own classification system. Second, 
the proposal argued that a standardized nomenclature system would 
8 H. Tjio and A. Levan, “The Chromosomes of Man,” Hereditas (1956), 42 . For a 
detailed account, see: M.A. Hulten, “Numbers, Bands and Recombination of Human 
Chromosomes: Historical A necdotes from a Swedish Student,” Cytogenetic and Genome 
Research 96, no. 1-4 (2002): 14-19; In their Hereditas publication, Tjio and Levan mention 
a study of chromosomes in embr yonic l iver mitosis conducted by Dr. Eva Hansen, who 
halted her research because her team was only able to locate forty-six of the presumed 
forty-eight human chromosomes. For further information, see: Daniel L. Hartl, Essential 
Genetics: A Genomics Perspective. (Burlington, M A: Jones & Bartlett Publishers, 2009); 
A lbert Levan, “Chromosome Studies on Some Human Tumors and Tissues of Normal 
Origin, Grown in Vivo and in Vitro at the Sloan–Kettering Institute.” Cancer 9 (1956): 
648–663; A ndrew J. Hogan, “The ‘Morbid A natomy’ of the Human Genome: Tracing the 
Obser vational and Representational Approaches of Postwar Genetics and Biomedicine. 
The Will iam Bynum Prize Essay,” Medical History 58, no. 3 (2014).
9 M. Demerec, E.A. Adelberg, A.J. Clark, and Philip E. Hartman, “A Proposal for Uniform 
Nomenclature in Bacterial Genetics,” Cytogenetics and Cell Genetics 54 (1966): 61-76.
10 Ibid.
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facilitate understanding and communication 
among scientists. Finally, it argued that the 
proposed nomenclature was beneficial because 
it was malleable enough to incorporate new 
genetic information. The authors affirmed 
that their “aims” were “uniformity, a unique 
designation for each strain, convenience for 
typing, editing, printing, record-keeping, and 
information retrieval.” Furthermore, they 
argued that a standardized nomenclature 
system would provide “adaptability, simplicity, 
and clarity” as well as “comprehension 
by workers in all areas of biology.” All of 
this would lead to “adaptability to new 
developments in the foreseeable future.”11 
The report concluded with an example 
of the system, a list of proposed standard 
symbols based on known gene function. Despite this well-organized 
proposal, seven years passed before the nomenclature question was again 
discussed in mapping meetings.12
Even so, the 1960s were a decade defined by advancements in the field 
of genetics, when much of the groundwork was laid for the creation of a 
genetic mapping project. A number of discoveries in microbiology further 
expanded opportunities for new research about the structure, function, 
and utilities of Deoxyribonucleic Acid (DNA). In 1960, just seven years after 
Rosalind Franklin, James Watson, and Francis Crick discovered the binary 
helical structure of DNA, Sydney Brenner, Francis Crick, François Jacob, 
and Jacques Monod solved a problem that had eluded geneticists for nearly 
a decade. Their research team, sponsored by the California Institute of 
Technology, had discovered Messenger Ribosomalnucleaic Acid (mRNA), 
a set of molecules that are responsible for transferring genetic information 
11 Ibid.
12 There is no clear answer as to why so much time would pass before any action was taken. 
One suggestion is that no single sponsoring institution or committee was assigned to 
undertake this project until 1974, when efforts to produce a human gene map were already 
well under way.
A low resolution karyotype of 
forty-six human chromosomes 
discovered by Tijo and Levan in 
1956. At that time, chromosome 
bands were not visible and a 
lack of organization made a 
nomenclature classification system 
difficult. (Image reprinted with 
permission from BioMed Central, 
acquisitioned from Hereditas.)
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to the cytoplasm, where genetic information 
is expressed.13 The next year, 34-year-old 
Marshall Nirenberg discovered that the 
genetic code was comprised of chemical units 
of DNA that specify how protein molecules 
are constructed. By 1966, Dr. Nirenberg had 
identified the first 63 sequences of human 
DNA.14 Two years later, in 1968, Nirenberg 
and his colleagues were awarded the Nobel 
Prize in Physiology and Medicine for “their 
interpretation of the genetic code and its 
function in protein synthesis.”15 Collectively, 
the discoveries of the 1960s prompted new 
opportunities for discovering and assembling 
a map of the human genome. As individual 
research groups, laboratories, universities, and 
private institutions independently sponsored 
continued genetic research, the issues of intelligibility and nomenclature 
norms were still part of an unfinished discussion among geneticists.
In 1960, four years after Tjio and Levan’s discovery prompted a 
discussion of a genetic nomenclature, British cytogeneticist Charles E. 
Ford convened a meeting on chromosomal nomenclature—a related, 
though not identical, subfield of microbiology. Later referred to as the 
Denver Conference for its location, the meeting was attended by 14 lead 
scientific investigators, all of whom had previously published human 
karyotypes (chromosome images). The group decided to number the 
chromosomes they had been researching and pair corresponding sets, to 
demarcate the sex chromosomes with “X” or “Y,” and to further categorize 
all chromosomes by size groups.16 The nomenclature system developed 
at the Denver Conference remained in use for decades following its 
13 F.H. Crick, L. Barnett, S. Brenner, R.J. Watts-Tobin, “General nature of the genetic code 
for proteins,” Nature 192, no. 4809 (1961): 1227–32 .
14 Nicholas Wade, “Marshall Nirenberg, Biologist Who Untangles Genetic Code, Dies at 82 .” 
New York Times, Januar y 21, 2010.
15 Franklin H. Portugal, The Least Likely Man: Marshall Nirenberg and the Discovery of the 
Genetic Code (Cambridge, Massachusetts: The MIT Press, 2015).
16 For further reading on the X and Y chromosomes, see Sarah R ichardson, Sex Itself: The 
Search for Male and Female in the Human Genome (Chicago: University of Chicago Press, 
2013).
A higher-resolution photograph 
of chromosomes 3, 9, and 22, 
published by the Standing 
Committee on Cytogenetic 
Nomenclature in Stockholm in 
1978. Note the visible difference 
in organization in contrast to the 
original 1956 karyotype on the 
previous page. (Image reprinted 
with permissions from S. Karger AG, 
Medical and Scientific Publishers.)
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establishment, having emerged in response to rapid breakthroughs in 
genetic research that created a need for a common scientific and medical 
vocabulary to further communication and organization in cytogenetics.17
The methodology devised at the Denver Conference for mapping 
chromosomes was highly intelligible, as reported in The Lancet:
“In designating a particular band, four items [were] required: 
(1) the chromosome number, (2) the arm symbol (i.e., the short 
or long arm of the chromosome), (3) the region number, and 
(4) the band number within that region. These items [were] 
given in order without spacing or punctuation. For example, 
1p33 indicated chromosome 1, short arm, region 3, band 3.”18
Cytogenetic chromosome maps became progressively more detailed 
with higher resolution photographic images and added their discoveries 
onto this framework. Initial depictions of chromosomes evolved into 
regions and bands, which served as landmarks for genetic diseases. 
Increased photographic resolution and visibility led to more complex 
mapping spaces, but the standardized nomenclature established 
at the Denver Conference facilitated chromosome mapping as a 
precursor to gene mapping. With a clear vocabulary and a consistent 
methodology for identifying and categorizing new information, human 
chromosome research prospered. Following the Denver Conference’s 
success in establishing a standardized nomenclature for chromosome 
mapping, geneticists later advocated for a similar organizational system 
for gene mapping.
Held in Rotterdam, the 1974 Human Gene Mapping Conference was 
the first formally recognized collective call for a nomenclature system 
for genes. Although participants established no formal guidelines at the 
meeting, a committee was formed to discuss the possibility of standardized 
terminology, as had been devised for chromosome mapping at the Denver 
Conference. The advantages were clear: increased organization in mapping, 
intelligibility and access to information for all scientists, and a decreased 
17 Standing Committee on Human Cytogenetic Nomenclature, An International System 
for Human Cytogenetic Nomenclature: Report of the Standing Committee on Human 
Cytogenetic Nomenclature, Hässelby Castle, Stockholm, Sweden, September 4-9, 1977.
18 J. Lejeune, et al., The Denver Conference Proceedings, “A Proposed Standard System of 
Nomenclature of Human Mitotic Chromosomes,” The Lancet, vol. 275, no. 7133 (1978): 
1063-1065.
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likelihood that geneticists in different labs would replicate research. The 
committee in charge of creating a nomenclature system consisted of Dr. 
Harry Harris from the University of Pennsylvania School of Medicine, 
Dr. Meera Khan of the Netherlands Department of Human Genetics, 
Tom Shows, microbiologist and editor of Cytogenetics and Cell Genetics, 
and Dr. Victor McKusick of Johns Hopkins School of Medicine. Deemed 
the Committee on Terminology, the group determined that “guidelines 
need[ed] to be established for naming the human genetic markers, including 
the terms to be used for loci, genes, phenotypes, and polypeptide chains.”19 
The Committee met again the following year, 1975, to discuss further the 
possibility of a nomenclature system, although a draft was not presented 
until the Human Gene Mapping Conference in Edinburgh in 1979.
Concerns about nomenclature in the Human Genome Project 
represented larger intellectual quandaries about the utility and limitations 
of language structures as an organizational system for processing scientific 
phenomena. Debates over gene nomenclature often referenced the biblical 
tower of Babel, highlighting the importance of devising a singular language 
19 “Report of the Committee on the Genetic Constitution of the X Chromosome,” from the 
International Workshop on Human Gene Mapping, Cytogenetics and Cell Genetics vol. 14, 
no. 3 (Rotterdam, Netherlands, 1974): 190-195.
The Tower of Babel by Dutch painter Pieter Brueghel the Elder (1563). Scientists 
often referenced this myth, which claims that language variation was a divine 
intervention to thwart humanity’s hubris. (Image courtesy of Wikimedia.)
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system when dozens of gene mapping languages were already in use. 
The question of which institution or lab had the authority to impose one 
language system over another loomed large. However, unlike the Denver 
Conference, where a common language system for chromosome mapping 
was devised within the scientific community, the standards for gene 
mapping were imposed from the outside, and not by scientists alone. In 
the five years that passed between 1974 and 1979, several events had already 
shaped the future prospects of the project, revealing the complexity of 
mapping without a single system of nomenclature and underscoring the 
centrality of public engagement in scientific standards creation in the early 
years of the HGP.
Public Influence on Nomenclature Standards
The year of 1977 was critical in advancing the prospect of a Human Genome 
Project. The previous June, researchers at Harvard and the Massachusetts 
Institute of Technology had developed a technique known as gene splicing. 
An early predecessor to recombinant DNA techniques, gene splicing 
allowed geneticists to insert a gene sequence into a pre-existing sequence 
and then replicate this new segment widely.20
This new technique did not stay in the laboratory long. By 1977, gene 
splicing caused controversy in both the media and scientific circles. The New 
York Times reported that Boston residents feared “that new, particularly 
durable viruses could escape from a laboratory.” Bostonians also expressed 
“commercial concerns” because the private universities were “not subject to 
the Government regulations that control gene splicing research at federally 
financed universities or hospitals.”21 In response to what later became 
known as the “Cambridge Gene Scare,” the Cambridge Public Health 
Department and Cambridge Town Council issued a set of ordinances 
regulating activities related to human genetic research. In the months 
prior to this regulation, the town council had threatened a moratorium on 
gene splicing research within the city.22 The moratorium was implemented 
after a Harvard newspaper published an article on genetic research titled, 
20 One of the earliest applications of gene splicing technolog y was a method to replicate 
human insulin.
21 “Gene-Splicing Concern in Boston,” The New York Times, May 31, 1981 .
22 Nicholas Wade, “Gene-splicing: Cambridge Citizens OK Research but Want More Safety,” 
Science vol. 195, no. 4275 (1977): 268–69.
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“Gene Splicing Controversy: Visions of Great Benefits and Grave Perils.”23 
Prior to this publication, which was highly circulated among the public, 
citizens were unaware of Harvard’s effort to study gene splicing and thus 
were ill-informed about the real or imagined dangers of such work. Since 
little was known about gene splicing and recombinant DNA efforts, the 
article produced legitimate concerns that “disease-producing bacteria 
like streptococci could, as a result of genetic engineering, accidentally be 
made immune to antibiotics and other drugs used to treat them,” or that 
“a bacterium that now inhabits the human body without doing harm might 
receive a genetic transplant that would cause it to begin manufacturing a 
deadly toxin.”24 As concerns circulated among the public, elected officials 
threatened a two-year moratorium on all genetic research in Cambridge. 
The prospect of discontinued research in the midst of exciting genetic 
breakthroughs further encouraged geneticists to establish laboratory 
research standards.
 The February 1977 issue of Science outlined the various local protocols 
developed in response to growing concerns over gene splicing technology. 
In a matter of months, Massachusetts, New York, California, Michigan, New 
Jersey, and Wisconsin had each issued protocols for gene splicing practices 
in regional laboratories. The New York attorney general’s environmental 
health bureau proposed a bill stipulating that all scientists engaged in gene 
splicing research had to be certified, trained, and monitored by the state 
health commissioner.25 Just one month earlier, in January of 1977, the NIH 
had revised their guidelines for recombinant DNA research.26 The updated 
guidelines, later given federal authority as national legislation, included 
regulations on genetic splicing and replication.27
After the public outcry, the NIH authorized cohesive standards for 
gene splicing, which solved the temporary concerns over recombinant DNA 
23 Sandra Stencel, “Controversy over Gene Splicing: Visions of Great Benef its and Great 
Perils,” Genetic Research , (Cambridge: Cambridge University Press, 1977).
24 Ibid.
25 Nicholas Wade, “Gene-splicing: At Grass-roots Level a Hundred Flowers Bloom,” Science 
195, no. 4278 (1977): 558–60.
26 0f f ice of the Director, NIH, “National Institutes of Health Environmental Impact 
Statement on NIH Guidelines for Research Involving Recombinant DNA Molecules, Part 
One and Part Two” (Bethesda: NIH Press, 1977), 147-438.
27 For a comprehensive histor y of Recombinant DNA Guidelines issued by the NIH, see 
D.S. Fredrickson, “A Histor y of the Recombinant DNA Guidelines in the United States,” 
Department of Health in Collaboration with the National Institutes of Health, (Bethesda: 
NIH Press, 2005).
148
Traces | The U NC-Chapel Hill Journal of Histor y
research, but did not address the larger question of nomenclature for gene 
identification and mapping, which had now gained broad public attention. 
The gene splicing ordinances issued by the NIH involved the consolidation 
of many local practices for gene splicing. The Cambridge Gene Scare 
also roused the attention of several national organizations, including 
the Occupational Safety and Health Administration, the Environmental 
Protection Agency, and the Food and Drug Administration. The creation 
of a single standardized system of uniform guidelines about gene splicing 
safety occurred only after public concern prompted changes in scientific 
regulation of genetic research, despite the fact that scientists had been 
discussing the practicality of creating some sort of guidelines for this 
research for years. Following the Cambridge Gene Scare, the benefits of 
standardization were increasingly evident: standardized research protocols 
would allow geneticists from various labs to clearly articulate their research 
findings, and standardized nomenclature would help scientists explain 
these findings in order to promote greater public understanding. Moreover, 
a standard nomenclature would prevent uninvited public distrust about 
new genetic research.
Nomenclature and Mass Information Management
Influenced by public debate and discussion within the scientific 
community, the nomenclature question also was tied to a number of 
practical concerns about information management related to the HGP. 
Many prominent institutions—including the NIH, the Department of 
Energy, and the National Science Foundation—considered sponsoring the 
standardization project, yet it was unclear which institution would be given 
primary responsibility for creating an intelligible nomenclature system. 
The continued use of multiple language systems in genetics threatened both 
clear communication among research sites and mapping efficiency, slowing 
down research and diluting its potential impact.
One way the HGP increased efficiency was through multi-site research, 
whereby each lab was assigned a specific portion of the human genome to 
map and catalog. Inter-institutional collaboration became especially crucial 
as continued discoveries of genetic regions in the 1980s produced massive 
amounts of information about the location of nucleotide sequences within 
genes. While new computer database technologies were implemented 
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to catalogue and map genetic data, the challenges of mass information 
management remained unresolved. The sheer quantity of information that 
had to be classified and named made this research challenging. Whereas 
the Denver naming system classified 46 chromosomes, each marked with 
bands and subregions, gene mapping produced much greater quantities of 
information: approximately 3.2 billion base pairs needed to be mapped.28 
As Vannevar Bush had so aptly anticipated, genetics appeared to be an 
endless frontier of new information. Debates ensued over how to best 
organize genetic data. Many believed that the search for information 
should be localized and comprehensive rather than general and expansive.29 
However, the approach most common to those who worked on the HGP 
was to first collect as many sequences as possible and presume that 
functional information about disease, inheritance, and mutation of 
these sequences would be added at a later date. This method prioritized 
information collection and was aligned with the HGP’s larger goals of 
mapping efficiency and timely project completion.
In 1980, approximately a decade before the formal commencement 
of the HGP, American advocates of the project began to voice their 
concerns about nomenclature and data organization, adding to debates 
previously held about genetic nomenclature more broadly. Proponents of a 
standardized nomenclature system, such as Dr. Donald Lindberg, director 
of the US National Library of Medicine, argued that a nomenclature system 
would significantly reduce the time and resources required to complete 
the human gene map.30 In 1984, Yale Professor and HGP architect Frank 
Ruddle insisted that gene mapping could not progress efficiently without a 
standardized mapping nomenclature.31 In a 1989 article, key HGP advocates 
argued that a consistent and comprehensive language system for genome 
mapping needed to replace the multitude of different mapping linguistics 
28 “Inside Life Science: Genetics by the Numbers,” NIH News in Health (Bethesda: NIH 
Press, 1977).
29 H. Wain, J. White, and S. Povey, “The Changing Challenges of Nomenclature,” 
Cytogenetics and Cell Genetics vol. 86, no. 2 (1999): 162-164.
30 Donald Lindberg, The Growth of Medical Information Systems in the United States 
(Lexington: Lexington Books Press, 1979), 194.979:194.
31 R .L. Miller, C. Partridge, W. K idd, F. H. Ruddle, “The Yale Human Gene Mapping 
Librar y,” Cytogenetic Genome vol. 37, no. 4 (1984): 394-397. The f irst genome-related 
methodolog y patent was granted in 1980 to Stanley Norman Cohen and Herbert Boyer 
for cloning the gene that codes for insulin. The l icensing royalties for this patent 
exceeded 300 mill ion dollars. See Gerald Karp, Cell and Molecular Biolog y: Concepts and 
Experiments (Wiley, 2009), 976-977.
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already in place at partner research sites. Concerned with the lack of a 
common language system, central HGP architects admonished: “Lest we 
replay the failed effort to build the tower of Babel, it would be wise to move 
decisively toward adoption.”32 In the absence of a standardized language 
system, geneticists had devised nomenclature systems specific to each 
research site, which often conformed to the organizational practices of each 
individual laboratory instead of adhering to a set of standards established to 
maintain consistency among the HGP’s varied research sites.
Furthermore, concerns over efficiency were also related to the 
diversion of significant funding toward the genome project during an 
“unprecedented” scientific funding crisis.33 The HGP was in its planning 
stages during the global economic recession of the 1970s and 1980s. 
Efficient research offered the potential for economic stimulation in the 
fields of science, technology, and healthcare. However, the adoption of 
an organizational nomenclature system, though advocated by prominent 
geneticists, appeared secondary to concerns over funding. While a 
pre-determined nomenclature system might have increased the time to 
HGP completion, such a system might also have circumvented the role of 
courts in genetic standards creation.
Legal Interpretations of Nomenclature
Prescient debates over the establishment of genetic nomenclature 
foreshadowed one of the most contentious ethical dilemmas of human 
genome research: the possibility that human DNA was patent-eligible. 
While the human body had long been central to debates about a gene map, 
the potential for profitable pharmaceutical and biomedical applications 
of genes invited entirely new questions about the commercialization 
of scientific research. As genetic nomenclature debates continued to 
materialize in the late 1970s, the Supreme Court heard a landmark case 
related to a patent application for a gene that produced insulin. Courtroom 
intervention demonstrated continued public and federal interest in 
32 C. Cantor, D. Bostien, L. Hood, M. Olson, “A Common Language for Physical Mapping of 
the Human Genome,” Science vol. 245, no. 4925 (September 29, 1989), 1434-1435.
33 National Center for Human Genome Research, Complaints and Criticisms File, Box 
BCD7, Human Genome A rchives National Reference Center for Bioethics at Georgetown. 
For further information, see M.A. Fortun, Mapping and Making Genes and Histories: 
The Genomics Project in the United States, 1980-1990, Ph.D. Thesis, Har vard University, 
(Cambridge: Har vard University Press, 1993).
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scientific research on human genetics and contributed to the discussion of 
systematization that had been taking place since the 1950s. The Supreme 
Court’s decision in this case revolved around the unanswered question of 
nomenclature.
On July 22, 1997, the US Federal Court of Appeals convened to 
review a suit brought against major pharmaceutical player Eli Lilly by the 
University of California. The lawsuit, later hallmarked as Lilly, concerned 
two patent applications filed by the respective litigants for licensing rights 
to a recombinant DNA method used to produce human insulin. John 
Shine, an Australian geneticist working at the University of California, 
was the first to file for a methods patent in May of 1977. After review from 
the US Patent and Trademark Office, Shine and his team of geneticists 
were encouraged to re-submit the application with the addition of a clear 
written description of the recombinant method they had developed to 
produce “vertebrae or mammalian” insulin.34 Since the adoption of the 
original United States Patent Act of 1793, written description had served 
as a required patent mechanism to ensure that an inventor could not 
extend the claims or benefits of the invention beyond its actual scope. It 
was also a standardized proof to ensure that those seeking a patent could 
intelligibly explain the method for arriving at the end product. According 
to the US Patent and Trademark Office, the written description clause 
for patent applications required that an applicant “show possession of the 
claimed invention” through a description of “the invention with all of its 
limitations.” Such applications were to be written in “clear, concise, and 
exact terms as to enable any person skilled in the art ... to make and use the 
same invention.”35 While geneticists at the University of California revised 
their patent application for recombinant insulin, the scientist’s inability 
to provide a sufficient written description of the structure and function of 
insulin evidenced a lack of common genetic language standards, such that 
the recombinant method could not be articulated and replicated by other 
geneticists. The nomenclature question, now intricately linked to concerns 
about scientific standards and patent applications, had suddenly unraveled.
34 Janice M. Mueller, “The Evolving Application of the Written Description Requirement to 
Biotechnological Inventions,” Berkeley Technolog y Law Journal vol. 13, no. 2 (1998): 629.
35 Christopher M. Homan, “Is Lilly Written Description a Paper Tiger? A Comprehensive 
Assessment of the Impact of Eli Lil ly and its Progeny in the Courts and PTO,” Albany 
Law Journal of Science and Technolog y, vol. 17 (2007). See also Regents University of 
California v. Eli Lil ly Company, 35 USC. 112 . 2000
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In the meantime, Eli Lilly and Co. had produced a highly profitable 
drug, Humulin, based on the recombinant techniques licensed by the 
University of California. From 1977 to 1980, Eli Lilly invested over 
60 million dollars on manufacturing facilities that were equipped to 
produce and distribute Humulin on a rapid and systematic scale.36
 
The 
company projected that, once Humulin reached the market, worldwide 
pharmaceutical sales would peak at 1.1 billion dollars. The patent request 
filed by Lilly for synthetic insulin was the catalyst intended to propel the 
pharmaceutical industry into a new economic frontier.37
On October 24, 1997, the Court ruled that Eli Lilly and Co. had not 
infringed upon either of the two patents held by the University of California 
for the recombinant plasmids utilized in the production of human insulin. 
Although geneticists at the university had filed multiple patent applications 
to license their technique, the Court rejected the validity of the patents 
based upon “a lack of adequate written description.”38 Furthermore, the 
Court ruled that the DNA patent for human insulin required “a precise 
definition, such as by structure, formula, or physical properties,” and that 
“an adequate written description of DNA require[d] more than a mere 
statement that it [was] part of the invention.” What was required, the Court 
ruled, “was a description of the DNA itself.”39
The ruling had both immediate and long-term consequences. In the 
short term, bioengineering patent applications were held to a more rigorous 
standard, which required a demonstration of the invention, the method, 
the product, and an intelligible nomenclature system to present these 
components. The Lilly decision also indicated the sober reality of scientific 
36 Gar y L. Nelson, Pharmaceutical Company Histories (Bismarck: Woodbine Publishers, 
1983). See also: E.J. K han Jr. All in a Century, The First 100 Years of Eli Lilly and Company 
(Indianapolis: Eli Lil ly and Company, 1976).
37 In the 1980 landmark case, Diamond v Chakrabarty, the Supreme Court adjudicated the 
question of whether genetically modif ied organisms, in this instance synthetic bacteria 
created to decompose crude oil sediments, were patent eligible. The court agreed to 
hear the case because the bacteria was deemed “an improvement on the constitution of 
matter” hearkening back to Locke’s argument that products of nature could be converted 
into property through a process of laborious improvement. The 5-4 ruling famously 
declared that anything “under the sun that is made, or perhaps improved upon, by 
man” was patent eligible. In 1980, the same year of Diamond v Chakrabarty, Bayh-Dole 
legislation permitted federally funded research to qualif y as patent eligible. A n important 
implication of the Bayh-Dole legislation was that revenue could be collected by the 
recipients (i.e, a company, university, or private R&D f irm) rather than returned to the 
federal government.
38 The Regents of the University of California v. Eli Lilly and Company, 119 US 43 (1997).
39 Ibid.
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commercialization—that inventors were not always the beneficiaries of their 
work. Whereas some legal scholars admonished Lilly as “an unmitigated 
disaster … with the potential for causing untold havoc in the biotechnology 
field,” others viewed the interpretation of written description as “a new 
challenge to validity” and a mechanism to ensure “sufficient disclosure of 
an invention.”40 Now often referenced in biotechnology and legal studies, 
the modified Lilly Written Description (LWD) doctrine set forth a highly 
contested and technically formidable standard for subsequent biomedical 
innovations. The decision highlighted the importance of using an 
intelligible nomenclature system that could be understood and verified by 
different scientists.
Some of the earliest questions posed by Human Genome map 
architects about the creation of a system of organizational nomenclature 
were paralleled by the US Federal Court as jurors considered the 
relevance of written description. A description of scientists’ method 
for retrieving recombinant insulin was insufficient without the DNA 
sequence description. The description needed to substantiate both genetic 
40 Christopher M. Homan, “Is Lilly Written Description a Paper Tiger? A Comprehensive 
Assessment of the Impact of Eli Lil ly and its Progeny in the Courts and PTO,” Albany Law 
Journal of Science and Technolog y, vol. 17 (2007).
The first printout of the human genome, presented as a series 
of books. (Photo courtesy of Wikimedia.)
154
Traces | The U NC-Chapel Hill Journal of Histor y
structure and function, with sequence-level precision, which Eli Lilly 
had successfully authored, despite the University of California having 
submitted a patent application several years prior to Lilly’s appropriation 
of the technique. The Court’s decision was not merely a vote for Eli Lilly 
and Co., it was also a vote for standardization and nomenclature. Excellent 
scientific research meant little if it could not be translated, interpreted, and 
applied consistently.41
The Nomenclature Debate’s Long-Term Effects
Tracing a history of the development of the HGP from 1945 to 1977 reveals 
that language catalyzed early intellectual momentum among the scientists 
and policy advisors who first envisioned a human gene map. As technological 
advances yielded new scientific discoveries about the structure and 
function of genes, talk of institutional sponsorship and information storage 
translated into practical concerns about the feasibility of one of the largest 
scientific undertakings of the twentieth century. Amidst this flurry and 
excitement, geneticists proposed the establishment of a nomenclature 
system, much like the one that had been successfully implemented to map 
human chromosomes at the Denver Conference in 1960. However, between 
the 1974 Rotterdam HGP Meeting and the 1979 Edinburgh HGP Meeting, 
where geneticists first devised a standardized system of nomenclature for 
the project, several events significantly altered the course of the HGP and 
its relationship to technology, society, and law. The Cambridge Gene Scare 
proved the need for a standardized nomenclature system by revealing how 
poor communication standards between scientists and laypersons created 
public distrust, and how the desperate need for clear communication about 
genetic research had allowed the public to intervene in scientific standards 
creation. Once realized, the need for nomenclature produced a number of 
organizational questions related to the description, classification, storage, 
and efficiency of newly discovered genes. When the nomenclature question 
remained unresolved in 1977, the year Shine and his team of geneticists at 
41 The following is a brief, but not comprehensive, l ist of cases that relied upon the new 
standards of Lilly Written Description: University of Rochester v. G.D. Searle & Co., 358 
US 916 (2004); Enzo Biochem Inc. v. Gen Probe Inc ., 323 US 956 (2002); Tronzo v. Biomet, 
Inc., 156 US 1154 (1998); Gentry Gallery Inc. v. Berkline Corp., 134 US 1473 (1998); Festo 
Corp v. Shokestu Kinzoku Kog yo Kabushiki Co., 535 US 722 (2002); J.E.M. Ag. Supply Inc. 
v. Pioneer Hi-Bred Intl ., 534 US (2001).
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the University of California filed for patent applications on human insulin, 
the imprecise presentation of their findings failed to pass the legal written 
description requirement, thereby allowing a federal court to determine the 
scientific standards necessary to obtain a patent.
The nomenclature question reveals a set of structural inconsistencies 
between the scientific community, the legal sphere, and the private sector. 
Legal scholars have suggested that the debates over intellectual property 
in the Human Genome Project transcended the structural legal framework 
in place to respond to emerging debates over biological property and 
ownership. The alteration of written description, from a method description 
to a comprehensive product description, set a precedent for future cases 
involving genetic research and ultimately reconfigured the boundaries 
and limitations of scientific discovery at the outset of the project. By 
understanding long-term debates over the use of nomenclature related to 
research on human genetics, historians can trace the development of the 
Human Genome Project over the course of almost 50 years after the end of 
the Second World War. Moreover, the involvement of lawyers, journalists, 
scientists, policy advisors, and community activists in the creation of 
a particular form of genetic nomenclature demonstrates the complex 
processes involved in scientific research in the twentieth century—a 
complexity that is unlikely to lessen in the years to come.
